Clinical Trial Update May/June 2026

• May 1, 2026

Emerging Therapeutic Targets in Noninfectious Uveitis and Scleritis

• by Tungsattayathitthan, Usanee , Goldstein, Debra A, Janetos, Timothy M

• April 30, 2026

Ocular Toxoplasmosis Review

Sleep, stress, and pregnancy emerge as potential drivers of ocular toxoplasmosis recurrence in recent retrospective study

• July 15, 2026

• 4 min

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized

• by Sumit Sharma, Phoebe Lin, Allen Hu, Eric B. Suhler, Meike Pauly-Evers, William Holmes, Zeinab Barekati, Daniela Willen, Lachlan Macgregor, Laura Steeples, Zdenka Haskova, Derrick Feenstra, David Silverman, Benedicte Passemard, Sascha Fauser, Marina Mesquida

• May 1, 2026